Literature DB >> 32888289

Identification of Hub Genes Associated with Hypertension and Their Interaction with miRNA Based on Weighted Gene Coexpression Network Analysis (WGCNA) Analysis.

Zongjin Li1, Jacqueline Chyr2, Zeyu Jia3, Lina Wang4, Xi Hu4, Xiaoming Wu4, Changxin Song5.   

Abstract

BACKGROUND Hypertension is one of the most widespread health conditions in the world, and the molecular mechanism of it is still unclear. In this study, we identified the hub genes (hub miRNA genes) associated with hypertension and explored the relationship between hypertension miRNA-gene by constructing a mRNA co-expression network and a miRNA co-expression network, which can help to reveal the mechanism and predict the prognosis of hypertension progression. MATERIAL AND METHODS Based on gene expression profile data of hypertensive samples from the Gene Expression Omnibus database, WGCNA was used to detect hypertension-related biomarkers and key mRNA and miRNA modules. Then, DAVID was used to perform gene-annotation enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) and miRPath were used for pathway analysis of mRNA and miRNAs genes. RESULTS We identified 3 key modules relating to hypertension, 2 mRNA modules named Msaddlebrown and Mgreenyellow and 1 miRNA module named Msalmon. In addition, 12 hub genes (RPL21, RPS28, LOC442727/PTGAP10, LOC100129599/RPS29P14, TBXAS1, FCER1G, CFP, FURIN, PECAM1, IGSF6, NCF1C, and LOC285296/UNC93B3) and 7 hub miRNAs (hsa-miR-1268a/b, hsa-miR-513c-3p, hsa-miR-4799-5p, hsa-miR-296-3p, hsa-miR-5195-5p, hsa-miR-219-2-3p, and hsa-miR-548d-5p) relating to hypertension were identified. HIF-1 signaling pathway and insulin signaling pathway were closely related to the 3 key modules. We also discovered 4 miRNAs (hsa-miR-548am-3p, hsa-miR-513c-3p, hsa-miR-182-5p, and hsa-miR-548d-5p) and 6 genes (IGF1R, GSK3B, FOXO1, PRKAR2B, HIF1A, and PIK3R1) were the core nodes in the hypertension-related miRNA-gene network, and hsa-miR-548am-3p was at the center of the network. CONCLUSIONS These findings will help improve the understanding of the pathogenesis of hypertension, and the discovered genes can serve as signatures for early diagnosis of hypertension.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32888289      PMCID: PMC7491244          DOI: 10.12659/MSM.923514

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


Background

Hypertension, also known as high blood pressure, is one of the most widespread health conditions in the world. It is one of the most dangerous factors affecting cardiovascular death. Every year, more than 17 million people die from cardiovascular disease. Hypertension is responsible for more than 45% of deaths due to heart disease, and 51% of deaths due to stroke [1]. The risk factors for hypertension include age, ethnicity, weight, diet, alcohol and tobacco use, gender, as well as existing health condition such as diabetes, high cholesterol levels, and chronic kidney disease. The pathogenic mechanism is even more complex, involving a variety of molecules and pathways [2]. Currently, hypertensive patients are treated with drugs such as diuretics, vasodilators, rapid-acting intravenous antihypertensive agents, and other drugs. Unfortunately, hypertension medications have many side effects such as cough, diarrhea, dizziness, drowsiness, depression, ulcers, and more. Since hypertension is a multiple-factor disease, further research is needed to reveal the molecular mechanism of hypertension and new biomarkers need to be discovered. The increased availability of high-throughput sequencing and microarrays along with the development of bioinformatics tools and algorithms has allowed for the discovery of several biomarkers that regulate blood pressure. For example, the anti-inflammatory cytokine interleukin-10 (IL-10) has a strong antihypertensive effect [3]; ENOS gene can increase plasma nitric oxide levels to reduce blood pressure [4]; and renin-angiotensin system (RAS) improves insulin resistance and prevents the development of renal hypertension [5]. Many miRNAs related to hypertension have also been discovered [6], such as miR-155 [7], miRNA-126 [8], miR-124 [9], and miR-150 [10]. Most of these studies only focused on one single gene or miRNA, and the identification of these gene targets are limited to just differential expression. Very few studies focused on expression profiles of multiple genes, and there is also insufficient attention to the high degree of interconnection between genes. The network of interactions between biomolecules provides an important basis for systematic research on disease. WGCNA is an R package, which is based on the similarity between genes to construct a weighted correlation network [11]. It has unique advantages in handling complex data with multiple samples, which is a powerful method to uncover basic mechanism of gene–disease relationships [12]. Using WGCNA, Zhang et al. discovered ten hub genes that could be used as biomarkers for oral squamous cell carcinoma tumors [13]. In another study, six hub genes were found to regulate the signaling pathway of clear cell renal cell carcinoma (ccRCC) [14]. Wu et al. applied WGCNA to the identification of potential therapeutic targets for angiotensin II (Ang II) induced hypertension [7]. Here, we utilized the WGCNA method to construct gene and miRNA modules, identified new biomarkers related to hypertension, and explored the relationship between hypertension and marker genes.

Material and Methods

Data sources and preprocessing

GSE75360, GSE75670, and GSE117261 datasets were downloaded from Gene Expression Omnibus (GEO) (). GSE75360 contained 10 hypertensive and 11 normal human gene expression data, (Illumina HumanHT-12 v.4.0 Expression BeadChip). GSE75670 contained 6 hypertensive and 6 normal human miRNA expression data (Exiqon mercury™ LNA™ microRNA array, 7th generation [miRbase v18]). GSE117261 contained 58 pulmonary arterial hypertension and 25 normal human gene expression data ([HuGene-1_0-st] Affymetrix Human Gene 1.0 ST Array [transcript (gene) version]). Data preprocessing procedures such as correction of expression matrix, quality evaluation of expression data, and sample clustering were conducted in R version 3.5.2. Network analysis with WGCNA software package was also conducted in R version 3.5.2. The overall analysis workflow is showed in Figure 1.
Figure 1

The workflow of this study.

Module construction base on WGCNA algorithm

WGCNA explores the complex relationships between genes and phenotypes by constructing scale-free co-expression networks. It transforms gene expression data into co-expression modules and then identifies hub genes in the modules. In this research, we constructed 2 weighted co-expression networks based on mRNA and miRNA expression data separately. The construction processes were the same except that some parameter values were different, so we only introduced the construction process of gene co-expression network. First, the correlation of all gene pairs was calculated to construct a similarity matrix. Second, the soft threshold β was a weighted parameter of the adjacent function, which the optimal value was obtained by the pickSoftThreshold function in the R package WGCNA [15]. Third, the TOM similarity function was used to convert the adjacency value into a TOM matrix. Then, using dissimilarity matrix dissTOM=1-TOM, we clustered the genes into the hierarchy to get the system clustering tree [13]. Fourth, mRNAs with similar expression profile were divided to the same module. According to the number of the genes and miRNAs, the minModuleSize of the mRNA was set to 50 and the minModuleSize of the miRNA was set to 30 [16]. Finally, we calculated the differences of the modules eigengenes, and set an appropriate cutline for the modules dendrogram to merge highly similar modules.

Identification of key modules in co-expressed networks

Two methods were used to identify key modules related to hypertension. The first method was to calculate the Pearson correlation coefficient and significance P-value of module eigengenes (MEs) and hypertension trait. Here, MEs represents the overall expression level of the gene module [17]. The second method calculates the gene significance (GS) and the module significance (MS). Here, GS is the correlation between a gene and the clinical features. MS is the average GS of all genes in a module [13]. Generally, the higher the absolute value of MS and GS, the more relevant the gene module is to hypertension.

Enrichment analysis of key modules

To further understand the function of a key module and its biological significance, we used the online functional annotation database DAVID (). For the mRNA modules, we used Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis to identify significantly enriched pathways (P-value <0.05). For miRNA modules, the online database miRPath V.3 () was used to predict miRNAs target genes for KEGG pathway enrichment [18].

Identify hub genes and hub miRNAs

This study used 2 methods to identify hub genes (miRNA) from key modules: 1) Importance threshold, and 2) MCC (maximal clique centrality function) algorithm which used the cytoHubba plugin. In the first method, hub genes are defined as genes with high GS value, high modular membership (MM) value, and low weighted P-value associated with genes and hypertension (P. weighted). MM was used to measure the importance of genes in modules [19]. The P-weighted value was calculated by the networkScreening function in WGCNA. A P. weighted value less than 0.05 was considered biologically significant [20]. In the second method, we used the MCC algorithm in cytoHubba plug-in from the Cytoscape software to identify hub genes [21].

Gene selection and hub gene verification

We used limma R package to analyze differently expressed genes (DEGs) between normal samples and hypertension samples in the dataset GSE75360 and set the cutoff value to log2FC< |0.182| and P-value <0.05. The volcanic map and hierarchical clustering analysis were performed by “ggplot2” and “pheatmap” package of R, respectively. Then, we used the jvenn () to draw Venn diagrams to overlap the genes in DEGs and hub genes [22]. We verified our hub genes using a different DEG dataset (GSE117261). We queried the role of hub genes through The Human Protein Atlas database () and used NCBI () to verify whether these hub genes could be used as biomarkers of hypertension.

Construction of miRNA-gene interactive network

DAVID and miRPath were used to identify enriched mRNA and miRNA pathways, respectively. Then, the overlapping pathways were chosen for network construction. Cytoscape was used to construct miRNA-gene interaction networks.

Results

Data preprocessing

After preprocessing, an expression matrix containing 29 595 genes was obtained. We calculated standard deviation (SD) of all genes, then, ranked the SD from large to small, and selected the top 6000 genes as the input data for the construction of the gene expression network. We performed the same preprocessing procedures on the miRNA expression matrix. A total of 1916 miRNAs were selected for co-expression network construction of miRNAs.

Construction of weighted co-expression network

To obtain a network that meets the scale-free topology criterion, we calculated network structures by using different soft-thresholding power range from 1 to 20. The scale-free topological fitting index of mRNA co-expression network reaches 0.8, when the soft-thresholding power was 14 (Supplementary Figure 1A, 1B), which met the scale-free network criterion. Then, the genes were clustered into modules by hierarchical clustering according to expression value, and the most similar modules were merged by setting the MEDissThres cutting line to 0.2 (Supplementary Figure 1C). Finally, 19 mRNA gene modules were identified (Figure 2). For miRNA co-expression networks, the soft-thresholding power was set at 9 and the scale-free topological fitting index at 0.88 (Supplementary Figure 2A, 2B). The MEDissThres cutting line was set to 0.1 (Supplementary Figure 2C), and 14 miRNA gene modules were identified (Figure 3). The relationship for each mRNA module was analyzed by drawing a network heat map (Supplementary Figure 3). The network heat map was produced with the modules in the miRNA co-expression network (Figure 4). The different colors in the vertical and horizontal axes stand for different miRNA modules. The yellow color in the middle area indicates a degree of connection for each miRNA module. The figure shows no significantly differences in the interaction between the modules, indicating that the miRNA modules had relatively high independence.
Figure 2

The cluster dendrogram of mRNA in mRNA expression data, each branch represents a gene, and each color below represents a co-expression module. The first ribbon represents the module detected by dynamic tree cutting, and the second ribbon represents the module after merging the similar module.

Figure 3

The cluster dendrogram of miRNAs in miRNA expression data.

Figure 4

The interaction relationship of co-expressed miRNAs. The different colors in the vertical and horizontal axes stand for different miRNAs modules. The yellow color in the middle area indicated a degree of connection for each miRNA module.

Identifying of key modules

We used 2 methods to identify key modules. The first method calculate the Pearson correlation and significance P-value between MEs and hypertension, and the other method calculates GS. We found 2 mRNA modules with significant correlations to hypertension, named Msaddlebrown and Mgreenyellow. Compared to other mRNA modules, the correlation coefficient of theese two modules were the largest (Figure 5A). In the miRNA co-expression network, the Msalmon module was highly related to hypertension (Figure 5B). In order to ensure the identified modules were significantly associated with hypertension, we calculated the GS in the modules and verify the key modules again (Figure 6A, 6B). For the mRNA co-expression network, the Msaddlebrown and Mgreenyellow modules had the largest GS scores at 0.451 and 0.410, respectively. For miRNA co-expression networks, the absolute GS value of Msalmon was 0.398. These GS values all indicate that these modules were significantly associated with hypertension.
Figure 5

(A) mRNA module-trait relationship. The MESaddlebrown module was most significantly related to hypertension, and the MEGreenyellow module was the second one. (B) miRNA module-trait relationship. The MESalmon module was most significantly related to hypertension.

Figure 6

(A) Module significance of mRNA. Distribution of average mRNA significance and errors in the modules related to hypertension. Salmon module is associated with high blood pressure. (B) Module significance of mRNA.

We performed GO analysis and KEGG analysis on the genes in the Msaddlebrown and Mgreenyellow modules to explore their biological significance (Supplementary Tables 1, 2). The Msaddlebrown module was related to RNA transcriptional translation, such as SRP-dependent co-translational protein targeting to membrane, translational initiation, and RNA binding. The Mgreenyellow module was involved in a variety of immune and metabolic processes, such as positive regulation of IL-6 production, positive regulation of transcription from RNA polymerase II promoter, glycoside catabolic process, and so on. Furthermore, KEGG pathway analysis showed enrichment in ribosome, HIF-1 signaling pathway, and osteoclast differentiation pathways. The significant pathways in Msalmon module were Hippo signaling pathway, adherens junction, and proteoglycans in cancer (Supplementary Table 3). Among them, the HIF-1 signaling pathway and the insulin signaling pathway were shared by both mRNA and miRNA modules.

Identification of hub genes and miRNAs

According to the definition of module connectivity, we calculated the MM and GS of the genes (miRNAs) in each of the key modules to select the hub genes (miRNAs). Then, we used the networkScreening function to obtain the P. weighted of each gene (miRNA). |MM| >0.8, |GS| >0.2 and P. weighted <0.05 were used as the identification criteria. Finally, 26 genes were obtained in the Msaddlebrown module (Supplementary Table 4), 53 genes were obtained in the Mgreenyellow module (Supplementary Table 5), and 22 miRNAs were obtained in the Msalmon module (Supplementary Table 6). We also import the files of these 3 key modules into Cytoscape software and used the plugin cytoHubba to identify and visualize pivotal genes and miRNAs (Supplementary Figure 4A–4C). We finally determine that there were 4 hub genes in Msaddlebrown module, 8 hub genes in Mgreenyellow module, and 7 hub miRNAs in Msalmon module (Table 1 and Supplementary Figure 5A–5C).
Table 1

Hub genes (MiRNAs) in key modules.

ModulesNameDEGsGSMMLog2FC
MsaddlebrownRPS28Down−0.650.884−0.282
MsaddlebrownRPL21Down−0.5550.863−0.290
MsaddlebrownLOC442727(PTMAP10)Down−0.5270.895−0.345
MsaddlebrownLOC100129599(RPS29P14)Down−0.4410.848−0.303
MgreenyellowTBXAS1Down−0.5170.926−0.316
MgreenyellowFCER1GDown−0.5970.922−0.478
MgreenyellowCFPDown−0.5500.867−0.347
MgreenyellowFURINDown−0.5440.872−0.316
MgreenyellowPECAM1Down−0.4870.844−0.243
MgreenyellowIGSF6Down−0.4850.860−0.412
MgreenyellowNCF1CDown−0.4500.879−0.354
MgreenyellowLOC285296(UNC93B3)Down−0.4510.852−0.174
Msaddlebrownhsa-miR-1268a/hsa-miR-1268bUp0.4160.9870.550
Msaddlebrownhsa-miR-513c-3pUp0.3540.9840.641
Msaddlebrownhsa-miR-4799-5pUp0.3920.9751.054
Msaddlebrownhsa-miR-296-3pUp0.4170.9740.408
Msaddlebrownhsa-miR-5195-5pUp0.4290.9720.915
Msaddlebrownhsa-miR-219-2-3pUp0.4510.9720.746
Msaddlebrownhsa-miR-548d-5pUp0.3990.9680.901

The verification and functional analysis of hub genes

Since Msaddlebrown and Mgreenyellow modules were negatively correlated with hypertension status, we wondered if the hub genes in these 2 modules were also negatively correlated with hypertension. We verified this by correlating hub genes expression values with hypertension status. There was a significant difference in hub genes (miRNAs) expression levels between normal and hypertensive group Supplementary Figure 6A–6C. We detected the expression of 12 hub genes by DEGs on original dataset GSE75360. Figure 7 shows the DEGs in a volcano map. The hierarchical clustering heat map of DEGs is shown in Supplementary Figure 7. We used the jvenn tool to overlap the hub genes in the Msaddlebrown and Mgreenyellow module and DEGs, respectively, and found 11 hub genes were both in the DEGs gene list and the hub genes lists (Supplementary Figure 8A, 8B). We used the same method to verify the hub gene in another dataset GSE117261 from the GEO database, and found TBXAS1, FCER1G, and IGSF6 were in the DEGs gene list and hub genes lists (Supplementary Figure 9). We compared the expression status of these three hub genes in normal and hypertensive patients from the GSE117261 dataset, and the results were consistent with those from the GSE75360 dataset (Supplementary Figure 10).
Figure 7

Volcano map of DEGs for GSE75360 dataset. The red dots on the right corresponds to 2-fold up changes with P-value less than 0.05, and the blue dots on the left means 2-fold down changes with P-value less than 0.05.

Analysis of miRNA-gene interaction networks

We discovered that the HIF-1 signaling pathway and the insulin signaling pathway were also found in the miRNA networks. In order to better understand the regulatory relationship between genes and miRNAs, the miRNA-gene interaction network was constructed, which was based on genes and miRNAs involving the same pathway. There was a total of 46 nodes (21 genes and 25 miRNAs) and 112 pairs of interactions in the miRNA-gene interaction network (Figure 8). We used the MCC algorithm in cytoHubba plugin to screen the top 10 miRNA-genes in the network. Four miRNAs (hsa-miR-548am-3p, hsa-miR-513c-3p, hsa-miR-182-5p, and hsa-miR-548d-5p) and 6 genes (IGF1R, GSK3B, FOXO1, PRKAR2B, HIF1A, and PIK3R1) were the core nodes of the network (Table 2, Figure 9), and hsa-miR-548am-3p was considered as the core regulator because it targeted these 6 genes.
Figure 8

The regulatory network of miRNAs and target genes. Among them, the green prisms are mRNA, the purple triangles are miRNA, pink solid lines represent the HIF-1 pathway, and the green dotted lines represent the insulin pathway.

Table 2

Top 10 in network MiRNA-gene ranked by MCC method.

RankNameScoreDEGs
1hsa-miR-548am-3p14Up
2hsa-miR-513c-3p11Up
2hsa-miR-182-5p11Up
4hsa-miR-548d-5p8Up
4IGF1R8Down
6GSK3B7Up
7FOXO16Up
7PRKAR2B6Up
7HIF1A6Down
7PIK3R16Up

miRNA – microRNA; MCC – Maximal Clique Centrality function.

Figure 9

Top 10 nodes in miRNA-gene network.

Discussion

In this study, mRNA and miRNA co-expression networks of hypertensive patients samples were constructed by using the WGCNA method. Out of the 19 identified mRNA modules, Msaddlebrown and Mgreenyellow had the most significant correlations to hypertension. For miRNAs, we identified 14 modules, of which Msalmon was the most significantly associated with hypertension. Finally, we identified 4 hub genes in the Msaddlebrown module, 8 hub genes in the Mgreenyellow module, and 7 hub miRNAs in the Msalmon module that were correlate with hypertension. Four miRNAs and 6 genes were also associated with the genetic susceptibility to hypertension. Our findings help us better understand the pathogenesis of hypertension, which in turn will provide us candidate biomarkers for clinical decision-making, potential therapeutic targets for accurate diagnosis, and treatment targets of hypertension. In the Msaddlebrown module, the GO analysis indicates that Msaddlebrown mainly refered to membrane formation, translation, and ribosome and rRNA processing. For the Mgreenyellow module, the insulin signaling pathway and the HIF-1 signaling pathway were enriched. The HIF-1 signaling pathway is reported to be important for development of pulmonary hypertension in chronic hypoxia [23]. The HIF-1 pathway is related to proliferation of pulmonary arterial smooth muscle cells (PASMCs), which is also a central pathological component for a kind of hypertension [24]. We found 12 hub genes associated with hypertension (RPL21, RPS28, LOC442727/PTGAP10, LOC100129599/RPS29P14, TBXAS1, FCER1G, CFP, FURIN, PECAM1, IGSF6, NCF1C, and LOC285296/UNC93B3). Other studies have shown that some of these hub genes are related to hypertension, such as TBXAS1, FCER1G, FURIN, and PECAM1. The enzyme encoded by the TBXAS1 gene can catalyze many reactions involving cholesterol, steroids, drug metabolism and other lipid synthesis; and a study has reported that TBXAS1 is a potent vasoconstrictor [25]. FCER1G is the Fc fragment of FcepsilonRI (IgE) receptor Ig and IgE expression on the cell surface of human platelets. It has been reported that FCER1G has a regulatory effect on diabetic kidneys, and as hypertension is closely related to this disease, it can be inferred that it has a certain effect on hypertension [26]. FURIN encodes proteases, and Li et al. reported that FURIN may be a candidate gene for human hypertension [27]. PECAM1 encoded immunoglobulin are involved in processes of leukocyte migration and angiogenesis, and studies have shown that PECAM-1 expression is upregulated in pregnancy-induced hypertensive patients [28]. Some hypertension-related pathways were found in the Msalmon module, which indicates that miRNA modules may also play a role in hypertension. The pathways include the adipocytokine signaling pathway, the thyroid hormone signaling pathway, the insulin signaling pathway, and the HIF-1 signaling pathway. The 3 key modules (Msaddlebrown, Mgreenyellow and Msalmon) have significant relations to hypertension, so we speculate that there may be regulatory relationships of the miRNAs and genes in the same pathway that affect blood pressure. In order to find out their relationship, we constructed a miRNA-gene regulatory network (Figure 8). We found 10 core nodes of the network (hsa-miR-548am-3p, hsa-miR-513c-3p, hsa-miR-182-5p, hsa-miR-548d-5p, IGF1R, GSK3B, FOXO1, PRKAR2B, HIF1A, and PIK3R1), and hsa-miR-548am-3p was considered the core regulator. Although these 4 miRNAs have not been reported to regulate hypertension, their target genes have blood pressure regulation effect. It is found that IGF1R, the target gene of hsa-miR-548am-3p, hsa-miR-513c-3p, hsa-miR-182-5p, and hsa-miR-548d-5p, may be associated to the genetic susceptibility to hypertension [29]. Due to its function in lung development, IGF-1R may play a role in the pathogenesis of pulmonary hypertension [30]. GSK3B, a target gene of hsa-miR-548am-3p, hsa-miR-513c-3p and hsa-miR-182-5p, encodes for the enzyme glycogen synthase kinase 3 beta (GSK3B). Platelet-derived factor (PDGF) can affect the abnormal growth of pulmonary arterial smooth muscle cells (PASMC) in pulmonary hypertension by inhibiting β-catenin (βC) activation of GSK3B [31]. FOXO1, a target gene of hsa-miR-548am-3p, hsa-miR-513c-3p, hsa-miR-182-5p, and hsa-miR-548d-5p, can control angiotensinogen (AGT) and Ang II levels and regulate blood pressure by regulating liver gene expression [32]. PRKAR2B, a target gene of hsa-miR-548am-3p and hsa-miR-548d-5p, may be a candidate gene for spontaneously hypertensive rats [33]. HIF1A, a target gene of hsa-miR-548am-3p, hsa-miR-513c-3p, and hsa-miR-182-5p, plays a vital role in the pathophysiology of embryonic angiogenesis and ischemic diseases. Sheng et al. found that gene polymorphism of HIF1A was associated with left ventricular hypertrophy in essential hypertension [34]. PIK3R1, a target gene of hsa-miR-548am-3p, hsa-miR-182-5p, and hsa-miR-548d-5p, plays a vital role in the metabolism of insulin, and PIK3CA/PIK3R1 may be involved in chronic thromboembolic pulmonary hypertension pathophysiology [35]. These results indicate that these 4 miRNAs may influence the occurrence of hypertension by regulating related target genes. This study had several limitations. First, our sample size was small and may not fully represent hypertension patients. Second, there is no biological experimental verification of the hub genes (miRNAs) and relationship between genes and miRNA. In a follow-up study, the molecular verification experiment will be conducted to uncover the molecular level mechanisms of miRNA-gene interactions and their relations to hypertension. Verified molecular markers can be used as new diagnostic indexes of hypertension in the future.

Conclusions

This study established a WGCNA-based gene expression data process workflow, identified 2 mRNA modules and 1 miRNA module related to hypertension, and provided potential candidate biomarkers for hypertension treatment. Our analysis revealed novel miRNA-gene interactions as well as central miRNAs and genes that play critical roles in hypertension. (A) Determining the soft-thresholding power in WGCNA. The left graph is a scale-free fitting index for analyzing various soft-thresholding powers (β). The graph on the right analyzes the average connectivity of various soft-thresholding powers. (B) The histogram verifies the selected β value is approached without scale. When the logarithm (log(k)) of the number of k-nodes is negatively correlated with the logarithm of the probability of occurrence of the node (log(p(k))), and the correlation coefficient is greater than 0.8, it is shown that the selected soft threshold accords with the standard. The left graph is the histogram of connectivity distribution when β is 14. The right image shows the scale-free topology checked when β=14. (C). The cluster dendrogram of gene modules eigengenes. (A) The average connection between the scale-free fitting index of various soft threshold power and all kinds of soft threshold power in miRNA expression data. The left graph is a scale-free fitting index for analyzing various soft-thresholding powers (β). The graph on the right analyzes the average connectivity of various soft-thresholding powers. (B) Verify whether the selected β value is close to scale-free. When β is 9, the scale-free topological fitting index reaches 0.89, which meets the scale-free network standard. (C) The cluster dendrogram of miRNA modules eigengenes. Analysis of the interaction relationship of co-expressed genes. The different colors of the horizontal axis and vertical axis represent different modules. The yellow brightness in the middle indicates the degree of connection of different modules. There is no significant difference in the interaction between the different modules, indicating a high degree of independence between these modules. (A) Diamonds represent genes. From red to yellow, the top 10 hub genes in the saddlebrown module are ordered in descending order. (B) Diamonds represent genes. From red to yellow, the top 10 hub genes in the greenyellow module are ordered in descending order. (C) Diamonds represent miRNAs. From red to yellow, the top 10 hub miRNAs in the salmon module are ordered in descending order. (A) Venn diagram of hub genes in saddlebrown module. (B) Venn diagram of hub genes in green-yellow module. (C) Venn diagram of hub miRNAs in salmon module. (A) The expression status of the hub genes in saddlebrown is negatively correlated with hypertension, indicating that it plays an important role in inhibiting the occurrence of hypertension, and the results shown in the figure. The expression status of the hub genes in greenyellow is negatively correlated with hypertension, indicating that it plays an important role in inhibiting the occurrence of hypertension, and the results shown in the figure are in accordance with the results of WGCNA. (B) The expression status of the hub genes in greenyellow is negatively correlated with hypertension, indicating that it plays an important role in inhibiting the occurrence of hypertension, and the results shown in the figure are in accordance with the results of WGCNA. (C) The expression status of the hub miRNA in salmon is negatively correlated with hypertension, indicating that it plays an important role in promote the occurrence of hypertension, and the results shown in the figure are in accordance with the results of WGCNA. Heat map hierarchical clustering reveals the comparison between high blood pressure samples and normal samples in DEGs of the GSE75360 dataset. (A) The common genes between DEGs and saddlebrown module were screened by Venn. It was found that 4 hub genes in saddlebrown were also in DEGs. (B) The common genes between the DEGs and greenyellow module were screened by Venn. Seven of the 8 hub genes in the greenyellow module are in DEGs. The common genes between the DEGs of the GSE117261 dataset and hub genes were screened by Venn hub genes in the DEGs. Expression of 3 hub genes in the GSE117261 datasets. The results of salmon module analysis in mirPath. 26 hub genes identified in the saddlebrown. 53 hub genes identified in the greenyellow. 22 hub genes identified in the salmon.
Supplementary Table 3

The results of salmon module analysis in mirPath.

KEGG pathwayp-value#genes#miRNAs
Hippo signaling pathway2.18E-079428
Adherens junction3.19E-075526
Proteoglycans in cancer3.19E-0712329
Pathways in cancer1.90E-0622933
Prostate cancer3.25E-066427
TGF-beta signaling pathway4.56E-065126
Pancreatic cancer1.62E-054824
Transcriptional misregulation in cancer1.62E-0510529
Protein processing in endoplasmic reticulum2.64E-0510627
Chronic myeloid leukemia3.12E-055026
FoxO signaling pathway8.58E-058329
Cell cycle9.30E-057628
Ubiquitin mediated proteolysis0.0001374288928
ErbB signaling pathway0.0002207585623
AMPK signaling pathway0.0002207587728
Hepatitis B0.0002207588128
Prion diseases0.0002347541412
Renal cell carcinoma0.0002347544524
Fatty acid biosynthesis0.000328055811
Wnt signaling pathway0.0003280558426
Endocytosis0.00032805512031
Colorectal cancer0.0005388124324
Focal adhesion0.0005554812227
Thyroid hormone signaling pathway0.0005912877125
Neurotrophin signaling pathway0.0005912877227
Bacterial invasion of epithelial cells0.0005923484824
Shigellosis0.0011598464225
SNARE interactions in vesicular transport0.0015071722214
Acute myeloid leukemia0.0015071723722
Non-small cell lung cancer0.0015071723522
Viral carcinogenesis0.00166485410431
Glycosaminoglycan biosynthesis – chondroitin sulfate/dermatan sulfate0.0016744891111
Glioma0.001828234023
Axon guidance0.002287997327
Adipocytokine signaling pathway0.0025822294620
mRNA surveillance pathway0.0025822295624
Choline metabolism in cancer0.0030523126326
Endometrial cancer0.003377323424
Arrhythmogenic right ventricular cardiomyopathy (ARVC)0.0040052753821
Small cell lung cancer0.006954035322
p53 signaling pathway0.006954034226
Melanoma0.0106157554226
PI3K-Akt signaling pathway0.01061575518229
Alanine, aspartate and glutamate metabolism0.0135568462318
Sphingolipid signaling pathway0.0135568466725
Signaling pathways regulating pluripotency of stem cells0.0193764137829
Insulin signaling pathway0.0208432288024
Rap1 signaling pathway0.02278378911328
Fc gamma R-mediated phagocytosis0.0326594715320
MAPK signaling pathway0.03493963513331
RNA degradation0.0394684884920
RNA transport0.0396959379428
HIF-1 signaling pathway0.0453069026027
Supplementary Table 4

26 hub genes identified in the saddlebrown.

Gene nameModule colorGSMMp.MMsaddlebrown
LOC346950Saddlebrown−0.6011977090.9576026731.01E-11
LOC730288Saddlebrown−0.6049784110.9488729795.79E-11
LOC651453Saddlebrown−0.4597492640.9420829041.84E-10
LOC729255Saddlebrown−0.5874409570.9220403992.86E-09
LOC441743Saddlebrown−0.4781529590.9129366427.89E-09
LOC644790Saddlebrown−0.5793493330.9123060018.43E-09
LOC730382Saddlebrown−0.5656692910.9004061062.69E-08
LOC442727Saddlebrown−0.5266853020.895310274.24E-08
LOC648343Saddlebrown−0.4875471640.8894300226.95E-08
LOC442454Saddlebrown−0.6157574810.8886928897.38E-08
RPS28Saddlebrown−0.6465536370.8840440651.07E-07
LOC645630Saddlebrown−0.637197210.8741657752.23E-07
RPL21Saddlebrown−0.554607340.862915394.81E-07
LOC100134273Saddlebrown−0.4616868340.8613819435.31E-07
LOC653156Saddlebrown−0.5316979380.8554357497.73E-07
LOC100129599Saddlebrown−0.4406509860.8479643451.21E-06
LOC100130154Saddlebrown−0.6480339570.8463826841.33E-06
LOC389156Saddlebrown−0.5765811090.8378234552.14E-06
IL27RASaddlebrown−0.5665950630.8375744292.17E-06
LOC645968Saddlebrown−0.5742222980.8338385572.66E-06
RPL12P6Saddlebrown−0.3708542110.8195476055.48E-06
LOC647673Saddlebrown−0.5500477450.8112697448.11E-06
HS.24119Saddlebrown0.422593803−0.808222969.32E-06
LOC641849Saddlebrown−0.5613823530.8079381499.44E-06
LOC643997Saddlebrown−0.624185760.8078943549.46E-06
LOC402644Saddlebrown−0.6023984810.8023129181.21E-05
Supplementary Table 5

53 hub genes identified in the greenyellow.

Gene nameModule colorGSMMp.MM greenyellow
PGDGreenyellow−0.4341294750.9466489778.60E-11
APLP2Greenyellow−0.6130944990.9354125965.05E-10
TYROBPGreenyellow−0.5016789450.9308064379.55E-10
TBXAS1Greenyellow−0.5172077920.9261437631.74E-09
FCER1GGreenyellow−0.5968148770.9217764392.95E-09
FKBP1AGreenyellow−0.579007580.9148806626.41E-09
LOC25845Greenyellow0.439117962−0.9075247761.37E-08
NUP214Greenyellow−0.5842521390.902555652.21E-08
SKAP1Greenyellow0.44444412−0.9005427022.66E-08
LOC642489Greenyellow−0.5473976050.8967947493.72E-08
CST3Greenyellow−0.4797270230.894672324.48E-08
LTBRGreenyellow−0.506216540.8920233355.61E-08
FCGRTGreenyellow−0.5482266460.8896469936.83E-08
TTYH3Greenyellow−0.4538366880.8807053351.38E-07
NCF1CGreenyellow−0.4503208970.8791072491.56E-07
PYCARDGreenyellow−0.4543808990.8750357462.10E-07
ESYT1Greenyellow0.514042042−0.8738550372.28E-07
RXRAGreenyellow−0.6710148340.8727320022.47E-07
ZNF792Greenyellow0.463899499−0.872195882.57E-07
FURINGreenyellow−0.543552380.8719546172.61E-07
SYKGreenyellow−0.4602319590.8701221462.97E-07
FUCA2Greenyellow−0.4532185530.8682780673.37E-07
CFPGreenyellow−0.5503028240.8668868753.70E-07
RAB5CGreenyellow−0.5545647910.8641315334.44E-07
C9ORF167Greenyellow−0.3651620490.8640615264.46E-07
SH3TC1Greenyellow−0.4186834160.8637832924.55E-07
IGSF6Greenyellow−0.4845646120.8597641885.89E-07
ACP6Greenyellow0.610300842−0.853515148.69E-07
CYBBGreenyellow−0.5674501990.8526366399.17E-07
LOC100133163Greenyellow0.516405892−0.8521775849.43E-07
LOC285296Greenyellow−0.450610830.8517851349.65E-07
LOC730278Greenyellow−0.7022608030.8512099499.99E-07
RGS19Greenyellow−0.5553675030.8477950311.22E-06
PECAM1Greenyellow−0.4869627290.843651821.55E-06
ARID3AGreenyellow−0.4628694810.8435738091.56E-06
ZNF385AGreenyellow−0.506003480.8413578031.76E-06
PPPDE2Greenyellow−0.5420193070.841019911.80E-06
LRP1Greenyellow−0.6231246490.8385158522.06E-06
IFI30Greenyellow−0.5951012240.834874172.51E-06
ARF3Greenyellow−0.3897120650.8336778782.68E-06
CTSDGreenyellow−0.5287313440.8301854913.22E-06
SIGLEC9Greenyellow−0.4854698650.8248536374.22E-06
PHF19Greenyellow0.447166744−0.8227979534.67E-06
C14ORF139Greenyellow0.410259281−0.8227070454.69E-06
C15ORF39Greenyellow−0.4283387110.8222890384.79E-06
UBTD1Greenyellow−0.4165382890.821378325.01E-06
DAPK1Greenyellow−0.6551588870.8198260795.41E-06
CYFIP2Greenyellow0.475140293−0.8193551685.53E-06
LOC653888Greenyellow−0.360544570.8189555195.64E-06
LOC644086Greenyellow−0.4513224360.8178702785.94E-06
ZNF827Greenyellow0.53343424−0.8147123246.90E-06
HMOX1Greenyellow−0.4788083290.8060517641.03E-05
LOC100129201Greenyellow−0.5314588890.8013455051.27E-05
Supplementary Table 6

22 hub genes identified in the salmon.

miRNA nameModule colorGSMMp.MMsalmon
hsa-miR-1268a/hsa-miR-1268bSalmon0.4160647530.9866106393.31E-09
hsa-miR-513c-3pSalmon0.3536932040.9835487749.23E-09
hsa-miR-4676-5pSalmon0.4276769910.9771118874.76E-08
hsa-miR-3065-5pSalmon0.3727234420.975393996.82E-08
hsa-miR-4799-5pSalmon0.3918326630.9753016696.94E-08
hsa-miR-296-3pSalmon0.4171250990.9739856368.98E-08
hsa-miR-4452Salmon0.4564588430.9720334221.29E-07
hsa-miR-5195-5pSalmon0.4285952010.9717358081.35E-07
hsa-miR-219-2-3pSalmon0.4506796490.9715918991.39E-07
hsa-miR-548d-5pSalmon0.398569760.968235232.41E-07
hsa-miR-3120-5pSalmon0.4291962730.9663989463.19E-07
hsa-miR-4478Salmon0.5050136870.9646460314.10E-07
hsa-miR-4789-3pSalmon0.4590457170.9555292541.27E-06
hsa-miR-548am-3pSalmon0.453311860.9550592551.34E-06
hsa-miR-500a-5pSalmon0.3932823260.9521952351.81E-06
hsa-miR-4712-3pSalmon0.4274390390.9507297992.10E-06
hsa-miR-3119Salmon0.4508938480.9502052842.22E-06
hsa-miR-1264Salmon0.5661312440.9473718322.91E-06
hsa-miR-212-5pSalmon0.4836763540.9328272549.62E-06
hsa-miR-548am-5p/hsa-miR-548au-5p/hsa-miR-548c-5p/hsa-miR-548o-5pSalmon0.4697407950.9044791895.32E-05
hsa-miR-4710Salmon0.51887670.8882729110.000113346
hsa-miR-4768-5pSalmon0.5290089680.8706227050.000228833
  33 in total

1.  Smooth Muscle Insulin-Like Growth Factor-1 Mediates Hypoxia-Induced Pulmonary Hypertension in Neonatal Mice.

Authors:  Miranda Sun; Ramaswamy Ramchandran; Jiwang Chen; Qiwei Yang; J Usha Raj
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

2.  Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development.

Authors:  Matteo Giulietti; Giulia Occhipinti; Giovanni Principato; Francesco Piva
Journal:  Cell Oncol (Dordr)       Date:  2016-05-30       Impact factor: 6.730

3.  PDGF-dependent β-catenin activation is associated with abnormal pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension.

Authors:  Jack Takahashi; Mark Orcholski; Ke Yuan; Vinicio de Jesus Perez
Journal:  FEBS Lett       Date:  2016-01-08       Impact factor: 4.124

4.  Serum levels of adhesion molecules in women with pregnancy-induced hypertension.

Authors:  H Zeisler; J C Livingston; C Schatten; C Tempfer; M Knöfler; P Husslein
Journal:  Wien Klin Wochenschr       Date:  2001-08-16       Impact factor: 1.704

5.  cytoHubba: identifying hub objects and sub-networks from complex interactome.

Authors:  Chia-Hao Chin; Shu-Hwa Chen; Hsin-Hung Wu; Chin-Wen Ho; Ming-Tat Ko; Chung-Yen Lin
Journal:  BMC Syst Biol       Date:  2014-12-08

6.  Racial differences in microRNA and gene expression in hypertensive women.

Authors:  Douglas F Dluzen; Nicole Noren Hooten; Yongqing Zhang; Yoonseo Kim; Frank E Glover; Salman M Tajuddin; Kimberly D Jacob; Alan B Zonderman; Michele K Evans
Journal:  Sci Rep       Date:  2016-10-25       Impact factor: 4.379

7.  Identifications of potential therapeutic targets and drugs in angiotensin II-induced hypertension.

Authors:  Xiaoli Wu; Ruihua Fan
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

8.  Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis.

Authors:  Xian-Guo Zhou; Xiao-Liang Huang; Si-Yuan Liang; Shao-Mei Tang; Si-Kao Wu; Tong-Tong Huang; Zeng-Nan Mo; Qiu-Yan Wang
Journal:  Onco Targets Ther       Date:  2018-05-15       Impact factor: 4.147

9.  ITLNI identified by comprehensive bioinformatic analysis as a hub candidate biological target in human epithelial ovarian cancer.

Authors:  JinHui Liu; SiYue Li; JunYa Liang; Yi Jiang; YiCong Wan; ShuLin Zhou; WenJun Cheng
Journal:  Cancer Manag Res       Date:  2019-03-25       Impact factor: 3.989

10.  Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC).

Authors:  Lushun Yuan; Liang Chen; Kaiyu Qian; Guofeng Qian; Chin-Lee Wu; Xinghuan Wang; Yu Xiao
Journal:  Genom Data       Date:  2017-11-04
View more
  5 in total

1.  Identification of miRNA and Their Regulatory Effects Induced by Total Flavonoids From Dracocephalum moldavica in the Treatment of Vascular Dementia.

Authors:  Mimin Liu; Guangzhi Shan; Hailun Jiang; Li Zeng; Kaiyue Zhao; Yiran Li; Ghulam Md Ashraf; Zhuorong Li; Rui Liu
Journal:  Front Pharmacol       Date:  2021-12-06       Impact factor: 5.810

Review 2.  Connections for Matters of the Heart: Network Medicine in Cardiovascular Diseases.

Authors:  Abhijeet Rajendra Sonawane; Elena Aikawa; Masanori Aikawa
Journal:  Front Cardiovasc Med       Date:  2022-05-19

3.  Identification of Key Pathways and Genes Related to the Development of Hair Follicle Cycle in Cashmere Goats.

Authors:  Jianfang Wang; Jie Sui; Chao Mao; Xiaorui Li; Xingyi Chen; Chengcheng Liang; Xiaohui Wang; Si-Hu Wang; Cunling Jia
Journal:  Genes (Basel)       Date:  2021-01-27       Impact factor: 4.096

4.  Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis.

Authors:  Vijayakrishna Kolur; Basavaraj Vastrad; Chanabasayya Vastrad; Shivakumar Kotturshetti; Anandkumar Tengli
Journal:  BMC Cardiovasc Disord       Date:  2021-07-04       Impact factor: 2.298

5.  Identification of Key Modules and Genes Associated with Major Depressive Disorder in Adolescents.

Authors:  Bao Zhao; Qingyue Fan; Jintong Liu; Aihua Yin; Pingping Wang; Wenxin Zhang
Journal:  Genes (Basel)       Date:  2022-03-05       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.